August 12, 2016
Mayo Clinic in the News Weekly Highlights
Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Editor, Karl Oestreich; Assistant Editor: Emily Blahnik Buzzfeed What You Should Know About Zika If You’re Going […]
Tags: ABC News, accupuncture, Addyson Cordes, AOL News, arthritis, Astrobiology, Becker’s Orthopedic & Spine, Best Hospitals, blood test, brain tumor, Breast Cancer, breast microbiome
May 20, 2016
Mayo Clinic in the News Weekly Highlights
Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Editor, Karl Oestreich; Assistant Editor: Emily Blahnik Forbes How Women Are Leading The Charge In Changing Healthcare […]
Tags: ABC15 Arizona, aging, air purifiers, alzheimers, Arkansas Online, Attn:, B12, birth control, bladder cancer, carotid-artery stenosis, Center for Individualized Medicine, chest pain
February 15, 2013
Medicine for the Rich Is About to Get Cheap Enough for Regular People
After years of exotic and very expensive machines sequencing DNA, the genomics industry finally looks poised for its cell phone moment…“Today, most companies have a specific niche. The full integrated package is being promised but is not really being offered,” says Dr. Gianrico Farrugia, the director of the Mayo Clinic Center for Individualized Medicine. With […]
Tags: Center for Individualized Medicine, DNA sequence, Dr. Gianrico Farrugia, genomics industry, Wired
April 18, 2012
Complete Genomics Well Positioned To Move From Research To Clinical In Genome Sequencing
OneMedRadio recently conducted an interview with Dr. Clifford A. Reid, the company’s President, Chief Executive Officer and Chairman since July 2005…CR: A great example is the Mayo Clinic earlier this year announced their new Center for Individualized Medicine and we at Complete Genomics are the whole human genome sequencing technology behind that center. It’s early […]
Tags: Center for Individualized Medicine, Complete Genomics Inc., Dr. Clifford A. Reid, OneMedRadio
February 15, 2012
Mayo Clinic signs California genome sequencing firm
To support its move toward personalized medicine, Mayo Clinic is joining forces with a California genome sequencing company. Complete Genomics Inc. announced Monday that Mayo Clinic’s Center for Individualized Medicine had chosen it to provide whole human genome sequencing on an outsource basis. Mayo Clinic will continue to do its own sequencing also, but this […]
Tags: Center for Individualized Medicine, Complete Genomics Inc., Dr. Gianrico Farrugia, human genome sequencing, Mayo Clinc's Center for Individualized Medicine
February 2, 2012
Mayo Clinic in the News Weekly Highlights
February 2, 2012 Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Whitney Benedett with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Karl Oestreich, manager enterprise media relations oestreich.karl@mayo.edu The […]
Tags: American Academy of Neurology, Center for Individualized Medicine, Dr. David Farley, Dr. James Levine, Dr. Martha Hartz, Dr. Rosebud Roberts, Gianrico Farrugia, KAAL, Mayo Clinic in the News, Mayo Clinic Medical School, mild cognitive impairment, NPR Shots Blog
January 26, 2012
Will Gene Sequencing Soon Be Part of Your Doctor Visit?
With its $6 billion hostile offer for Illumina Inc., Swiss drug-giant Roche Holding AG is making an expensive and risky bet that genetic mapping will soon be common practice in doctors offices and hospitals…”We are convinced this is going to markedly change the way we are looking after our patients,” said Gianrico Farrugia, head of […]
Tags: Center for Individualized Medicine, Gianrico Farrugia, Illumina Inc., Roche Holding AG